Adenosine receptor antagonism in the prevention of acute cyclosporine A-nephrotoxicity in normal, diabetic and hypertensive rats.
Heyne
N
N
Centre of Clinical Pharmacology Tübingen-Stuttgart, Germany.
Wolf
S
S
Petersen
P
P
Merten
S
S
Schöber
W
W
Erley
C M
CM
Risler
T
T
Osswald
H
H
D000818:Animals; D016572:Cyclosporine / Q000633:toxicity*; D003921:Diabetes Mellitus, Experimental / Q000503:physiopathology*; D006973:Hypertension / Q000503:physiopathology*; D007166:Immunosuppressive Agents / Q000633:toxicity*; D007668:Kidney / Q000187:drug effects* / Q000503:physiopathology; D058915:Purinergic P1 Receptor Antagonists; D051381:Rats; D013311:Streptozocin
D007166:Immunosuppressive Agents; D058915:Purinergic P1 Receptor Antagonists; D013311:Streptozocin; D016572:Cyclosporine